A BILL TO BE ENTITLED AN ACT RELATING TO THE HANDLING OF ANTINEOPLASTIC AGENTS TO PREVENT DISEASE AND INJURY CAUSED BY EXPOSURE.
Senate committee substitute makes the following changes to the 2nd edition.
Amends GS 95-127 (Definitions) to remove the definitions forantineoplastic drugand andhazardous drugsadded in the previous edition to the Occupational Safety and Health Act of North Carolina (OSHA). Adds a definition to OSHA forantineoplastic agent, defined as a chemotherapy drug or cytotoxic drug used to treat cancer patients and some non-cancer patients. Also amends the "whereas clauses" to conform to the changes to GS 95-127.
Amends proposed GS 95-156 to direct the Commissioner of Labor to adopt rules establishing requirements for handling antineoplastic agents in facilities where there is occupational exposure to those agents (was, establish requirements for the handling of antineoplastic and other hazardous drugs in health care facilities). Requires that the rules must be consistent with, but not exceed, recommendations issued by theNational Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) in the publication NIOSHAlert: Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs inHealth CareSettings,as published in 2004, including subsequent editions and amendments.
Deletes provision that rules adopted under this section do not apply to an entity accredited by the Joint Commission on Accreditation ofHealthcareOrganizations or otherrecognized hospital accreditation body that has filed certain documentation regarding the accreditation process with the Department of Labor.
Directs the Commissioner of Labor to adopt rules to implement this act no later than January 1, 2016 (was, January 1, 2015). Provides that the rules adopted under this section are not subject to GS 150B-19.1(e), GS 150B-19.1(f), GS 150B-19.1(h), and GS 150B-21.4. Requires the Commissioner to establish an advisory workgroup that includes hospitals, organizations representing health care personnel, and other interested stakeholders to develop the rules required by this act.
Amends the long title to reflect changes to the bill content.